Research and Development Committee (Avishkar Cell)
The institute has its research and development cell through which the research activities of the undergraduate, postgraduate and doctoral programs in pharmacy are carried out. The constitution of the R and D cell includes the Principal as Chairman and R and D coordinators and Heads of Department as members.
| Sr. No. | Name of the Members | Position |
| 01. | Dr. J.N. Sangshetti | In-charge |
| 02. | Dr. Santosh Mokale | Member |
| 03. | Dr. M.H.Dehghan | Member |
| 04. | Dr. H.D.Une | Member |
| 05. | Dr. Mrs.Rana Z.Ahmed | Member |
| 06. | Dr. Subur Khan | Member |
| 07. | Dr. Furquan Khan | Member |
| 08. | Adv. Ashfaq Patel | Patent Attorney |
Research Output of the college:-
Publications /Presentations/Seminars, Workshops, Conferences attended by Faculty The faculty has published their research work in various National and International journals of repute. The faculties are also motivated to participate in various International and National Workshops/Symposia and present their research work.
| Research Output of the College: | ||
| 1 | Total publications | 964 |
| 2 | Total Patents | 10 |
| 3 | Total Citations | 5350 |
| 4 | Total Books published | 22 |
| 5 | Total Presentations at conferences | 272 |
College Patents
|
Sr.No. |
Title |
Application No. |
Inventors |
Application Year |
Status (Published/Granted) If Published date of publication |
|
1 |
A topical antimicrobial herbal preparation |
931/MUM/2014A |
Dehghan Mohammed Hassan, Abubakar S. Bawazir
|
21/03/2014 |
Granted Nov 2020 |
|
2 |
Synthesis of novel 3-(2-chloroquinolin-3-yl)-N-cyclohexylquinoxalin-2-amine and antibacterial activity of thereof |
91/MUM/2015A |
JN Sangshetti Firoz Khan, Zahid Zaheer, Rajendra Patil Rohidas Arote Devanand Shinde
|
05/01/2015 |
Granted Sept 2019
|
|
3 |
Diethyl (Substituted Phenyl/heteryl)(2(2-Oxoindolin-3 ylidene)Hydrazinyl)Methyl phosphonate compounds as Anticancer Agents |
201621035782 A |
Anna Nikalje, Rekha Gajare |
19/10/2016 |
Published 28/10/2016 Granted March 2020 |
|
4 |
Biodegradable Antibiotic Drug Delivery System and Preparation Thereof |
201641022803 A |
Vijayakrishna Kari, Shrikant Sadashivrao Patil , Jaiprakash Sangshetti |
02/07/2016 |
Published 12/08/2016 Granted October 2021 |
|
5 |
Quantitative Trait Loci Analysis for assessing Ragrs blast resistanceusing machine learning technique |
2021106339 (Australian Innovation Patent) |
Shukla Piyushkumar, Mitra J Chatterjee, Imran AneesMirza Shahed Baig, Kumar Agrawal |
August 2021 Applied |
November 2021 Granted |
|
6 |
Stabilized statin Formulation
|
528/MUM/2010
|
Furquan Khan,Mukhtar Siddiqui, M.H.Dehghan |
26/02/2010 |
Published 28/5/2010 |
|
7 |
Microwave assisted Synthesis of Nanosponges and Pharmaceutical composition containing the same thereof |
3299/MUM /2011
|
Zahid Zaheer, Rana Zainuddin, Gunjan Patil, Furquan Khan,Sangshetti Jaiprakash, Mazahar Farooqui |
23/11/2011 |
Published 8/3/2013 |
|
8 |
Novel 2-(substituted-aryl)-3-(2- oxoindolin-3-ylidene)amino)- thiazolidin-4-one compounds as potential anticonvulsant agents |
2099/MUM/2012
|
Anna Pratima Nikalje |
25/04/2013 |
Published 03/05/2013 |
|
9 |
Once a day Oral Sustained Release Gastroretentive Formulation of Lafutidine |
3203/MUM/2011
|
Furquan Khan, M.H.Dehghan,Sham Gadlinge, Moizul Hasan, Dinesh Dhamecha, Maqdoom Farooqui |
11/11/2011 |
Published 28/6/2013 |
|
10 |
Co-crystals and pharmaceutical composition |
469/MUM/2014
|
Mr. Mahesh Sarode, Mr. Dipak Gadade, Dr. Sanjay S. Pekamwar, Dr. Lahoti S.R. |
10/02/2014 |
Published 13/11/2015 |
|
11 |
Novel Process for Synthesis of Clobetasol Propionate |
201821008147 A
|
Patil Sanjeev, Anil Bobade, Jaiprakash Sangshetti Devanand Shinde |
06/03/2018 |
Published 20/07/2018 |
|
12 |
Modified Release Pharmaceutical Composition containing Hydrochlorthiazide |
201921005199 A
|
Dr. Swapnil Sharma Vikas D. Singhai Dr. Sarvesh Paliwal Kanika Verma Gaurav Gujral Pujan Kamani Dhaval Patel Dr. Yogesh Raichandani Piyush chudiwal Swaroop Lahoti Navneet Joshi |
09/02/2019 |
Published 01/03/2019 |
|
13 |
Pharmaceutical Composition For the treatment of diabetic neuropathy and process of preparation thereof |
201921029053 A
|
Hemant Une, Khan Dureshawar,Mohd Mubasshir |
18/07/2019 |
Published 30/08/2019 |
|
14 |
Transdermal Patch Formulation Comprising extracts of Momordica Charantia |
202121007320 A
|
Dr. Mirza Shahed Baig, Miss. Syeda Farheen Fatema, Syed Nafeesuddin |
22/02/2021 |
Published 26/02/2021 |
|
15 |
A Natural Biodegradable Polymeric SYSTEM OF Pomegranate Peel Powder and its derivatives thereof |
202121003106 A
|
Moizul Hasan, Syed Ayaz Ali, Furquan Khan, Imran Anees, Subur Khan |
22/01/2021 |
Published 12/02/2021 |
|
16 |
Nanosponge Formulation comprising Ezetimibe |
201921049651 A
|
Bhusnure O G, Jagtap S R, Gholave S B, Giram P S, Sangshetti J N |
03/12/2019 |
Published 04/06/2021 |
|
17 |
Novel hydroxamic acid derivatives as Histone Deacetylase Inhibitors for the treatment of cancer and process for preparation thereof |
202121043736A
|
Shubhangi Manikpriya, Imran Anees, Mirza Shahed Baig |
Septembet 2021 |
Published 29/10/2021 |
|
18 |
A novel Process for the Synthesis of Ciclesonide |
202121054088
|
Ajit Kharpe, Prashant Netankar, Santosh Moklae |
November 2021 |
Published 03/12/2021 |
|
19 |
A novel Process for the Synthesis of Desfluorotriamcinolone |
202121054089
|
Ajit Kharpe, Prashant Netankar, Santosh Moklae |
November 2021 |
Published 03/12/2021 |
|
20 |
Comparative evaluation and optimization of different drug delivery system |
202021018837 A
|
Dr. Swaroop Lahoti, Piyush Chudiwal |
02/05/2020 |
Applied |
|
21 |
Novel 2 Styryl-1 methyl- 1,4,5,6- tetrahydropyrimidines as Fumarate reductase inhibitors |
TEMP/E-1/47753/2020-MUM
|
Santosh N. Mokale,Akshay R. Gawade, Shweta A. More, Santosh V. Deshmukh, Nikhilkumar S. Sakle |
03/10/2020 |
Applied |
|
22 |
Antitubercular Compound and process for preparation thereof |
TEMP/E-1/3456/2021-MUM
|
Pratiksha Sonwane, Mirza Shahed Baig |
23/01/2021 |
Applied |
|
23 |
Novel N-4-(Substituted Aryl)N-2-(4- chloropyrimidin-2yl)6,7- dimethoxy quinazoline- 2,4 diamines as Anticancer Agents |
20221007599
|
Santosh N. Mokale, Shweta A. More, Nikhilkumar S. Sakle, Archana Dhavale |
13/02/2022 |
Published 15/04/2022 |
